78 related articles for article (PubMed ID: 2449617)
1. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
NIDA Res Monogr; 1987; 76():157-61. PubMed ID: 2449617
[No Abstract] [Full Text] [Related]
2. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1988 Aug; 246(2):441-8. PubMed ID: 2457074
[TBL] [Abstract][Full Text] [Related]
3. Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects.
McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
NIDA Res Monogr; 1983 Apr; 43():238-44. PubMed ID: 6192340
[No Abstract] [Full Text] [Related]
4. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
[TBL] [Abstract][Full Text] [Related]
5. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
[TBL] [Abstract][Full Text] [Related]
6. Acute abstinence syndrome after epidural injection of butorphanol.
Weintraub SJ; Naulty JS
Anesth Analg; 1985 Apr; 64(4):452-3. PubMed ID: 3985392
[No Abstract] [Full Text] [Related]
7. Acute opioid physical dependence in humans: naloxone dose response effects.
Heishman S; Stitzer M
NIDA Res Monogr; 1988; 81():195-201. PubMed ID: 3136361
[No Abstract] [Full Text] [Related]
8. Physiological and subjective effects of hydromorphone in postaddict volunteers.
McCaul M; Stitzer M; Bigelow G; Liebson I
NIDA Res Monogr; 1982 Apr; 41():301-8. PubMed ID: 6181412
[No Abstract] [Full Text] [Related]
9. Withdrawal syndrome is not precipitated when butorphanol is added to opiate or opioid therapy. A comment on intranasal butorphanol-induced apraxia reversed by naloxone.
Barkin RL
Pharmacotherapy; 1996; 16(5):969. PubMed ID: 8888097
[No Abstract] [Full Text] [Related]
10. Ophthalmic naloxone elicits abstinence in opioid-dependent subjects.
Sanchez-Ramos JR; Senay EC
Br J Addict; 1987 Mar; 82(3):313-5. PubMed ID: 3471262
[No Abstract] [Full Text] [Related]
11. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
[TBL] [Abstract][Full Text] [Related]
13. The effects of buprenorphine in methadone-dependent volunteers.
Strain EC; Bigelow GE; Preston KL; Liebson I
NIDA Res Monogr; 1990; 105():584. PubMed ID: 1715035
[No Abstract] [Full Text] [Related]
14. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
Wright C; Bigelow GE; Stitzer ML
NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
[No Abstract] [Full Text] [Related]
15. Abuse liability assessment of buprenorphine-naloxone combinations.
Bigelow GE; Preston KL; Liebson IA
NIDA Res Monogr; 1987; 76():145-9. PubMed ID: 2449616
[No Abstract] [Full Text] [Related]
16. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
17. Nature and incidence of conditioned responses in a methadone population: a comparison of laboratory, clinic, and naturalistic settings.
Childress AR; McLellan AT; O'Brien CP
NIDA Res Monogr; 1986; 67():366-72. PubMed ID: 3092092
[No Abstract] [Full Text] [Related]
18. Buprenorphine and naloxone alone and in combination in opioid-dependent humans.
Preston KL; Bigelow GE; Liebson IA
Psychopharmacology (Berl); 1988; 94(4):484-90. PubMed ID: 2453895
[TBL] [Abstract][Full Text] [Related]
19. A case of physical and psychological dependence on butorphanol.
Harshe DG; Mate OS; Cholera RM; Kale S
J Opioid Manag; 2015; 11(2):112-3. PubMed ID: 26035913
[No Abstract] [Full Text] [Related]
20. Morphine physical dependence in the dog.
Martin WR; Eades CG; Thompson WO; Thompson JA; Flanary HG
J Pharmacol Exp Ther; 1974 Jun; 189(3):759-71. PubMed ID: 4858404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
